X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1272) 1272
Book Review (414) 414
Publication (102) 102
Book Chapter (8) 8
Dissertation (4) 4
Conference Proceeding (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (992) 992
humans (960) 960
pegylated interferon-alpha-2b (740) 740
antiviral agents - therapeutic use (576) 576
gastroenterology & hepatology (516) 516
male (465) 465
female (453) 453
hepatitis c (418) 418
interferon-alpha - therapeutic use (414) 414
hepatitis c, chronic - drug therapy (409) 409
ribavirin (403) 403
middle aged (374) 374
treatment outcome (369) 369
adult (360) 360
interferon (357) 357
drug therapy, combination (331) 331
pegylated interferon (330) 330
ribavirin - therapeutic use (330) 330
recombinant proteins (323) 323
hepatitis c virus (265) 265
polyethylene glycols - therapeutic use (265) 265
interferon-alpha-2b plus ribavirin (254) 254
therapy (249) 249
virus-infection (242) 242
peginterferon alpha-2a (240) 240
combination therapy (216) 216
genotype (212) 212
hepacivirus - genetics (206) 206
infectious diseases (206) 206
biological response modifiers (203) 203
hepatitis c - drug therapy (200) 200
sustained virological response (187) 187
hepatitis (185) 185
interferon-alpha - administration & dosage (185) 185
aged (183) 183
antiviral agents - administration & dosage (181) 181
pharmacology & pharmacy (176) 176
virology (176) 176
care and treatment (172) 172
plus ribavirin (170) 170
health aspects (161) 161
initial treatment (160) 160
antiviral agents - adverse effects (152) 152
infection (145) 145
randomized-trial (145) 145
viral load (143) 143
hepatitis c, chronic - virology (140) 140
hepatocellular-carcinoma (139) 139
hepacivirus - drug effects (138) 138
ribavirin - administration & dosage (136) 136
chronic hepatitis-c (130) 130
interferon-alpha - adverse effects (127) 127
drug therapy (125) 125
oncology (124) 124
chronic hepatitis c (123) 123
antiviral therapy (122) 122
polyethylene glycols - administration & dosage (118) 118
recombinant proteins - therapeutic use (113) 113
combination (111) 111
virus diseases (111) 111
cirrhosis (110) 110
liver (110) 110
hcv (108) 108
polyethylene glycols (107) 107
rna, viral - blood (106) 106
peginterferon alpha-2b (103) 103
analysis (102) 102
hepatitis b, chronic - drug therapy (102) 102
hepatitis c, chronic - complications (102) 102
hiv infections - complications (102) 102
immunology (102) 102
ribavirin - adverse effects (102) 102
human-immunodeficiency-virus (101) 101
interferons - therapeutic use (101) 101
antiviral agents (96) 96
hiv (95) 95
risk factors (91) 91
efficacy (89) 89
lamivudine (89) 89
medicine & public health (88) 88
hiv infections - drug therapy (87) 87
gastroenterology and hepatology (85) 85
hepatitis b (85) 85
liver transplantation (83) 83
virus (82) 82
melanoma (81) 81
prospective studies (80) 80
recurrence (80) 80
research (80) 80
surgery (80) 80
virological response (80) 80
peginterferon (79) 79
time factors (78) 78
transplantation (78) 78
medicine, general & internal (77) 77
randomized controlled-trial (76) 76
polyethylene glycols - adverse effects (74) 74
digestive system diseases (73) 73
hepatology (73) 73
hiv-infected patients (73) 73
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1223) 1223
Spanish (17) 17
French (12) 12
Japanese (12) 12
German (11) 11
Chinese (1) 1
Korean (1) 1
Polish (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 3, pp. 495 - 501
Journal Article
Ocular Immunology and Inflammation, ISSN 0927-3948, 07/2017, Volume 27, Issue 1, pp. 1 - 8
Journal Article
PEDIATRIC INFECTIOUS DISEASE JOURNAL, ISSN 0891-3668, 04/2018, Volume 37, Issue 4, pp. 287 - 291
Background: Autoimmune thyroid disease and thyroid dysfunction are common in adults receiving interferon (IFN)-based treatment for chronic hepatitis C (CHC).... 
INFECTIOUS DISEASES | VIRUS-INFECTION | MANAGEMENT | hypothyroidism | hepatitis C | GUIDELINES | IMMUNOLOGY | interferon | ALPHA-2B PLUS RIBAVIRIN | VIROLOGICAL RESPONSE | CELIAC-DISEASE | autoimmunity | children | PEGINTERFERON ALPHA-2B | ADOLESCENTS | PEGYLATED INTERFERON | PEDIATRICS | DYSFUNCTION
Journal Article
Hepatitis Monthly, ISSN 1735-143X, 2014, Volume 14, Issue 3, pp. e15729 - e15729
Background: Approximately 5% of hepatitis B virus (HBV) carriers are coinfected with hepatitis D virus (HDV). HBV/HDV coinfection is a major cause of cirrhosis... 
Iran | Interferon-alpha | Hepatitis D | VIRUS-INFECTION | 12-MONTH COURSE | RESOLUTION | COINFECTION | RIBAVIRIN | COMBINATION | ALPHA-INTERFERON | PEGYLATED INTERFERON | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | ANTIGEN
Journal Article
WORLD JOURNAL OF GASTROENTEROLOGY, ISSN 1007-9327, 09/2010, Volume 16, Issue 35, pp. 4400 - 4409
AIM To analyze the efficacy and safety of a combination therapy of pegylated interferon (PEG-IFN) alpha-2b plus ribavirin (RBV) in older Japanese patients (65... 
VIRUS-INFECTION | Pegylated interferon | HUMAN LYMPHOBLASTOID INTERFERON | INITIAL TREATMENT | RANDOMIZED-TRIAL | 65 YR | Ribavirin | Gerontology | HEPATOCELLULAR-CARCINOMA | THERAPY | COMBINATION TREATMENT | DISEASE STUDY-GROUP | Hepatitis C virus | GASTROENTEROLOGY & HEPATOLOGY | ELDERLY-PATIENTS
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 55, pp. 111 - 121
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2012, Volume 57, Issue 3, pp. 534 - 540
Journal Article
Ocular Immunology and Inflammation, ISSN 0927-3948, 01/2019, Volume 27, Issue 1, pp. 15 - 22
Purpose: To assess the long-term efficacy and safety of pegylated interferon alpha-2b (peg-IFN-α-2b) for severe uveitis associated with Behçet's disease.... 
interferon therapy | treatment | uveitis | pegylated interferon alpha-2b | Behçet's uveitis | Behcet's uveitis | ATTACHMENT | SAFETY | PHARMACOKINETICS | DISEASE | OPHTHALMOLOGY | COMPLICATIONS | ALPHA-2A THERAPY | HEPATITIS-C
Journal Article
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, ISSN 1077-4114, 01/2016, Volume 38, Issue 1, pp. E26 - E28
A 13-year-old male with suprasellar cystic craniopharyngioma initially controlled with sequential subtotal resections and proton-beam irradiation was later... 
THERAPY | ONCOLOGY | pegylated interferon alpha-2b | craniopharyngioma | ISCHEMIC OPTIC NEUROPATHY | PEDIATRICS | visual field | HEMATOLOGY
Journal Article
CHROMATOGRAPHIA, ISSN 0009-5893, 12/2014, Volume 77, Issue 23-24, pp. 1661 - 1669
Covalently attaching polyethylene glycol (PEGylation) to therapeutic proteins is an increasingly important tool for improving stability, pharmacokinetic and... 
Interferon alpha-2b | Size exclusion chromatography | CHEMISTRY, ANALYTICAL | Stability | Pegylated interferon | CHROMATOGRAPHY METHOD | SERUM-ALBUMIN | RECOMBINANT HUMAN INTERFERON-ALPHA-2B | BIOCHEMICAL RESEARCH METHODS | Biopharmaceuticals | FORMULATION | PEGYLATION
Journal Article
JOURNAL OF NEUROSURGERY-PEDIATRICS, ISSN 1933-0707, 12/2012, Volume 10, Issue 6, pp. 498 - 503
Object. Previous studies of systemic and intralesional administration of nonpegylated interferon have shown efficacy against craniopharyngioma. Pegylaion of... 
SURGERY | MANAGEMENT | pediatric neurosurgery | pegylated interferon | COMBINATION | ALPHA-INTERFERON | oncology | CYSTIC-CRANIOPHARYNGIOMA | CLINICAL NEUROLOGY | recurrent craniopharyngioma | RADIATION-THERAPY | INTRATUMORAL CHEMOTHERAPY | GROWTH | SEQUELAE | SQUAMOUS-CELL CARCINOMA | PEDIATRICS
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 08/2009, Volume 16, Issue 8, pp. 586 - 594
Journal Article
CANCER, ISSN 0008-543X, 06/2006, Volume 106, Issue 11, pp. 2397 - 2405
Journal Article
Journal of Interferon and Cytokine Research, ISSN 1079-9907, 12/2016, Volume 36, Issue 12, pp. 681 - 688
Journal Article
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, ISSN 0277-2116, 12/2013, Volume 57, Issue 6, pp. 694 - 699
Background and Objective:The course of chronic hepatitis C in children is often mild or asymptomatic, but may lead to liver cirrhosis and neoplasm. The aim of... 
ribavirin | MANAGEMENT | virologic response | chronic hepatitis C | ALPHA-2B PLUS RIBAVIRIN | SUSTAINED VIROLOGICAL RESPONSE | TRIAL | NUTRITION & DIETETICS | THERAPY | PEGINTERFERON ALPHA-2A | children | PEDIATRICS | pegylated interferon-2b | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
INTERNAL MEDICINE, ISSN 0918-2918, 2015, Volume 54, Issue 20, pp. 2551 - 2560
Objective This study evaluated the efficacy and safety of triple therapy with telaprevir (TVR), pegylated interferon alpha-2b (PegIFN-alpha-2b) and ribavirin... 
SYSTEM | MEDICINE, GENERAL & INTERNAL | PLUS RIBAVIRIN | ribavirin | telaprevir | pegylated interferon alpha-2b | chronic hepatitis C | SIMEPREVIR | HCV | INHIBITOR | PEGINTERFERON | TO-TREAT PATIENTS
Journal Article
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, ISSN 1841-8724, 12/2011, Volume 20, Issue 4, pp. 377 - 382
Background: Antiviral therapy for chronic hepatitis D (delta) is not yet satisfactory, although it appears to be the only means to alter the progressive... 
peginterferon alpha-2b | PEGYLATED INTERFERON-ALPHA-2B | COMBINATION | GASTROENTEROLOGY & HEPATOLOGY | Hepatitis D | antiviral therapy
Journal Article
ANTICANCER RESEARCH, ISSN 0250-7005, 09/2012, Volume 32, Issue 9, pp. 3901 - 3909
Based on the results of European Organization for Research and Treatment of Cancer (EORTC) 18991 trial, the US Food and Drug Administration (FDA) approved... 
HIGH-RISK MELANOMA | STAGE-III MELANOMA | CHRONIC HEPATITIS-C | melanoma | adjuvant therapy | RIBAVIRIN | CANCER | TRIAL | ONCOLOGY | review | HIGH-DOSE INTERFERON-ALPHA-2B | CUTANEOUS MELANOMA | PEGYLATED INTERFERON-ALPHA-2B | PROGNOSTIC-SIGNIFICANCE | PEG-Interferon alpha-2b | Reviews | Risk groups | Melanoma | Clinical trials | Adjuvants | Interferon | Survival | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.